bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.060
+0.020 (1.92%)
At close: Mar 9, 2026, 4:00 PM EDT
1.180
+0.120 (11.32%)
Pre-market: Mar 10, 2026, 5:33 AM EDT
bioAffinity Technologies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 5 | 14 | 14 | 13 | - | - |
| Market Cap Growth | -63.19% | 1.49% | 4.34% | - | - | - |
| Enterprise Value | -2 | 15 | 11 | 1 | - | - |
| Last Close Price | 1.06 | 27.30 | 44.12 | 48.00 | - | - |
| PS Ratio | 0.70 | 1.52 | 5.52 | 2788.17 | - | - |
| PB Ratio | 0.41 | 5.45 | 2.88 | 1.21 | - | - |
| P/TBV Ratio | 0.70 | 33.57 | 5.34 | 1.21 | - | - |
| EV/Sales Ratio | - | 1.62 | 4.40 | 147.57 | - | - |
| Debt / Equity Ratio | 0.08 | 0.58 | 0.33 | 0.02 | -0.97 | -0.91 |
| Net Debt / Equity Ratio | -0.78 | 0.15 | -0.26 | -1.01 | -0.85 | -0.90 |
| Net Debt / EBITDA Ratio | 0.71 | -0.05 | 0.16 | 2.79 | -4.54 | -3.84 |
| Net Debt / FCF Ratio | 0.82 | -0.05 | 0.21 | 2.60 | -4.88 | -4.49 |
| Asset Turnover | 0.75 | 1.27 | 0.25 | 0.00 | - | - |
| Inventory Turnover | 161.36 | 259.63 | 144.93 | - | - | - |
| Quick Ratio | 3.44 | 0.72 | 1.62 | 10.03 | 0.10 | 0.01 |
| Current Ratio | 3.65 | 0.87 | 1.77 | 10.51 | 0.11 | 0.01 |
| Return on Equity (ROE) | -245.18% | -242.44% | -99.84% | - | - | - |
| Return on Assets (ROA) | -71.71% | -75.95% | -48.85% | -36.77% | -172.53% | - |
| Return on Capital Employed (ROCE) | -113.00% | -262.70% | -133.50% | -36.30% | 19.00% | 23.70% |
| Earnings Yield | -309.55% | -63.74% | -56.80% | -60.89% | - | - |
| FCF Yield | -178.67% | -51.78% | -43.37% | -32.04% | - | - |
| Buyback Yield / Dilution | -102.65% | -38.61% | -94.43% | -68.17% | -0.02% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.